For example, malignant insulinomas have a low incidence and expression density of the GLP-1 receptor, but show high expression of the somatostatin receptor, where in benign insulinomas the expression profile is more favorable for the GLP-1R4, 18, 19. The gene discussed is GLP1R; the disease is pancreatic insulinoma.